The Natural Choice for Bespoke Healthcare Compliance

The Natural Choice for Bespoke Health and Social Care Compliance

THE CQC'S NEW FRAMEWORK | Interpreting employee wellbeing and management statements

Class 4 Medicines Defect Information: Altan Pharma Limited, Phenylephrine 0.08 mg/ml – solution for injection/infusion, EL(22)A/29

Published On:

16 June 2022

Published In:

Altan Pharma Limited have identified an error relating to the product packaging. The incorrect concentration of phenylephrine base is provided on the overwrapping bag label.

MDR Number

MDR 198-05/22

Company name

Altan Pharma Limited

Product description

Phenylephrine 0.08 mg/ml – solution for injection/infusion PL 46788/0024

Batch Number Expiry Date Pack Size First Distributed
FE221001 05/2024 10 bags of 100ml April 2022

Active Pharmaceutical Ingredient: Phenylephrine hydrochloride

Brief description of the problem

Altan Pharma Limited have identified an error relating to the product packaging. The incorrect concentration of phenylephrine base is provided on the overwrapping bag label.

  • The label states that: 1 ml contains 0.08 mg of phenylephrine base. Each bag of 100 ml contains 10 mg of phenylephrine base that corresponds to 10 mg of phenylephrine hydrochloride.
  • However, the correct label should state: 1 ml contains 0.08 mg of phenylephrine base. Each bag of 100 ml contains 8 mg of phenylephrine base that corresponds to 10 mg of phenylephrine hydrochloride.

Information on the product carton, bag label and SmPC remain correct, and this product is not being recalled.

Advice for healthcare professionals

Healthcare professionals are advised to exercise caution when using the product and in relation to the impacted batch and should refer to the label dose on the actual bag which remains correct.

As stated above, each bag of 100 ml contains 8 mg of phenylephrine base that corresponds to 10 mg of phenylephrine hydrochloride and this information should be used when using this product during dispensing and administering (i.e., for dose adjustments). Healthcare professionals may wish to retain a copy of this notification, and Altan Pharma Limited have confirmed that they will be supplying this notification with each pack.

Advice for patients

Patients are not required to take any action at this time. This product is administered by healthcare professionals directly and the medicine itself is not affected. If you have concerns about a medicine you may be using, please contact your healthcare professional.

To read the full article please click HERE

Request a Callback with Our Specialist Team!

Leave your contact details along with a few lines about the nature of your enquiry and a specialist member of our team will get in touch.

This website uses cookies to ensure you get the best experience on our website. Learn more

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors